LA MESA, Calif. (KGTV) - After a Little League baseball coach was diagnosed with pancreatic cancer, he's finding that the team and community he's cared for since 2019 are now returning the favor.

In vivo, C57BL/6J male mice were treated with HFD+STZ to establish a type 2 diabetes mouse model were investigated the effects of regulation of macrophage polarization in the pancreas and visceral ...

In type I diabetes, the body’s immune system attacks insulin-producing pancreatic beta cells—a subtype of islet cells. To restore insulin production and simultaneously curtail an immune response, ...

The young patient from Garhwa, Jharkhand, came in with a rare pancreatic tumour known as a Solid Pseudopapillary Epithelial Neoplasm (SPEN), necessitating the intricate Whipple’s procedure ...

A new study has linked new-onset type 2 diabetes to an increased risk for developing certain obesity-related cancers, including colorectal, pancreatic, and liver cancers. This increased risk was ...

NEW YORK – Silexion Therapeutics on Friday revealed plans to clinically develop its siRNA candidate SIL204 as a treatment for KRAS-driven pancreatic cancer. The firm said recent preclinical studies of ...

Background: Pancreatic adenocarcinoma (PAAD) ranks among the most lethal malignancies worldwide. Current treatment options have limited efficacy, underscoring the need for new therapeutic targets.

There's said to be more that 200 different types of cancer, and pancreatic cancer is one of the most prevailing types. Pancreatic cancer makes up for around three percent of all cancers in the US and ...

Cabozantinib significantly delayed disease progression in advanced pancreatic and extra-pancreatic neuroendocrine tumors, as shown in the phase 3 CABINET trial. The trial demonstrated a median PFS ...

Neuroendocrine tumors that start in the pancreas tend to be more aggressive and have a poor prognosis. The FDA has approved a supplemental application for Cabometyx (cabozantinib) to treat adult and ...

Perineural invasion (PNI) is a pivotal prognostic factor in pancreatic cancer associated with aggressive tumor behavior and adverse patient outcomes. The recognized clinical impact of PNI highlights ...